insulin
- Generic Name
- insulin
FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)
Phase 2
Recruiting
- Conditions
- Type 1 Diabetes Mellitus
- Interventions
- First Posted Date
- 2023-11-01
- Last Posted Date
- 2025-04-17
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 192
- Registration Number
- NCT06111586
- Locations
- 🇭🇺
Investigational Site Number : 3480002, Nyíregyháza, Hungary
🇭🇺Investigational Site Number : 3480006, Székesfehérvár, Hungary
🇮🇹Azienda Ospedaliera Universitaria Meyer IRCCS-Site Number : 3800003, Florence, Firenze, Italy
Clinical Trial to Determine the Efficacy and Safety of Insulin Eye Drops in Dry Eye in Patients with Topical Hypotensors
- First Posted Date
- 2023-08-30
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- Barbara Burgos Blasco
- Target Recruit Count
- 100
- Registration Number
- NCT06017362
- Locations
- 🇪🇸
Hospital Clinico San Carlos, Madrid, Spain
Blood Glucose Management in Intensive Care Units
Recruiting
- Conditions
- HyperglycemiaInsulin HypoglycemiaGlucose Test Site Bleeding
- First Posted Date
- 2023-03-20
- Last Posted Date
- 2023-04-06
- Lead Sponsor
- French Society for Intensive Care
- Target Recruit Count
- 525
- Registration Number
- NCT05775770
- Locations
- 🇫🇷
CHU Caen, Caen, France
Comparison of 2 Hyperglycemia-correction Scales in Hospitalized Patients
- First Posted Date
- 2023-03-03
- Last Posted Date
- 2023-03-03
- Lead Sponsor
- Hospital Universitario Clinica San Rafael
- Target Recruit Count
- 116
- Registration Number
- NCT05752929
Insulin Versus Hyaluronic Acid in Management of Periodontal Defects
Phase 3
Recruiting
- Conditions
- Periodontal DiseasesPeriodontal Pocket
- Interventions
- First Posted Date
- 2023-02-28
- Last Posted Date
- 2023-02-28
- Lead Sponsor
- October University for Modern Sciences and Arts
- Target Recruit Count
- 30
- Registration Number
- NCT05746676
- Locations
- 🇪🇬
Al-Azhar University, Faculty of Dentistry, Cairo, Egypt
Clinical Trial to Determine the Effectiveness and Safety of Topical Insulin in Dry Eye
Phase 4
Recruiting
- Conditions
- InsulinDry Eye
- Interventions
- First Posted Date
- 2023-01-20
- Last Posted Date
- 2024-10-22
- Lead Sponsor
- Barbara Burgos Blasco
- Target Recruit Count
- 120
- Registration Number
- NCT05692739
- Locations
- 🇪🇸
Hospital Clinico San Carlos, Madrid, Spain
Nebulized Salbutamol Facilitate Management of Hyperkalemia Postreperfusion During Liver Transplantation
Not Applicable
Not yet recruiting
- Conditions
- Liver Transplantation
- Interventions
- First Posted Date
- 2022-10-21
- Last Posted Date
- 2022-10-21
- Target Recruit Count
- 100
- Registration Number
- NCT05589441
Real-world Evaluation of GLP-1 Receptor Agonists (GLP-1RA) on Efficacy and Persistence, Adherence and Therapeutic Inertia Among Type 2 Diabetes Adults With Obesity
Completed
- Conditions
- Type 2 DiabetesObesity
- Interventions
- First Posted Date
- 2022-09-10
- Last Posted Date
- 2022-09-28
- Lead Sponsor
- Ana Palanca
- Target Recruit Count
- 26944
- Registration Number
- NCT05535322
- Locations
- 🇪🇸
INCLIVA, Valencia, Spain
Effect of Adding Metformin to Insulin in Uncontrolled Diabetic Patients During the 3rd Trimester of Pregnancy
- First Posted Date
- 2022-07-29
- Last Posted Date
- 2023-02-21
- Lead Sponsor
- Cairo University
- Target Recruit Count
- 150
- Registration Number
- NCT05479214
- Locations
- 🇪🇬
Cairo University, Cairo, Egypt
Intranasal Insulin for COVID-19-related Smell Loss
- First Posted Date
- 2022-07-18
- Last Posted Date
- 2022-07-18
- Lead Sponsor
- Universidad Panamericana
- Target Recruit Count
- 27
- Registration Number
- NCT05461365
- Locations
- 🇲🇽
Universidad Panamerican, Mexico City, Mexico
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath